413 related articles for article (PubMed ID: 27026331)
1. 25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese.
Camozzi V; Frigo AC; Zaninotto M; Sanguin F; Plebani M; Boscaro M; Schiavon L; Luisetto G
Osteoporos Int; 2016 Aug; 27(8):2593-602. PubMed ID: 27026331
[TBL] [Abstract][Full Text] [Related]
2. Impact of a cholesterol membrane transporter's inhibition on vitamin D absorption: A double-blind randomized placebo-controlled study.
Silva MC; Faulhauber GAM; Leite ÉN; Goulart KR; Ramirez JMA; Cocolichio FM; Furlanetto TW
Bone; 2015 Dec; 81():338-342. PubMed ID: 26208795
[TBL] [Abstract][Full Text] [Related]
3. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
[TBL] [Abstract][Full Text] [Related]
4. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects.
Sneve M; Figenschau Y; Jorde R
Eur J Endocrinol; 2008 Dec; 159(6):675-84. PubMed ID: 19056900
[TBL] [Abstract][Full Text] [Related]
5. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study.
Wamberg L; Pedersen SB; Richelsen B; Rejnmark L
Calcif Tissue Int; 2013 Jul; 93(1):69-77. PubMed ID: 23591713
[TBL] [Abstract][Full Text] [Related]
6. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
[TBL] [Abstract][Full Text] [Related]
7. Obese young adults exhibit lower total and lower free serum 25-hydroxycholecalciferol in a randomized vitamin D intervention.
Holmlund-Suila E; Pekkinen M; Ivaska KK; Andersson S; Mäkitie O; Viljakainen H
Clin Endocrinol (Oxf); 2016 Sep; 85(3):378-85. PubMed ID: 27146258
[TBL] [Abstract][Full Text] [Related]
8. Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
Bishop CW; Strugnell SA; Csomor P; Kaiser E; Ashfaq A
Am J Nephrol; 2022; 53(6):446-454. PubMed ID: 35551374
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D
Al-Bayyari N; Al-Zeidaneen S; Hailat R; Hamadneh J
Nutr Res; 2018 Nov; 59():65-71. PubMed ID: 30442234
[TBL] [Abstract][Full Text] [Related]
10. High-dose oral colecalciferol loading in obesity: impact of body mass index and its utility prior to bariatric surgery to treat vitamin D deficiency.
King RJ; Chandrajay D; Abbas A; Orme SM; Barth JH
Clin Obes; 2017 Apr; 7(2):92-97. PubMed ID: 28146321
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency.
Diamond T; Wong YK; Golombick T
Osteoporos Int; 2013 Mar; 24(3):1101-5. PubMed ID: 22422304
[TBL] [Abstract][Full Text] [Related]
12. Serum Parathyroid Hormone Responses to Vitamin D Supplementation in Overweight/Obese Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Lotito A; Teramoto M; Cheung M; Becker K; Sukumar D
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28272298
[TBL] [Abstract][Full Text] [Related]
13. Low serum 25(OH)D levels are assocıated to hıgher BMI and metabolic syndrome parameters in adult subjects in Turkey.
Tosunbayraktar G; Bas M; Kut A; Buyukkaragoz AH
Afr Health Sci; 2015 Dec; 15(4):1161-9. PubMed ID: 26958017
[TBL] [Abstract][Full Text] [Related]
14. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women.
Gallagher JC; Yalamanchili V; Smith LM
J Steroid Biochem Mol Biol; 2013 Jul; 136():195-200. PubMed ID: 23246640
[TBL] [Abstract][Full Text] [Related]
15. A high weekly dose of cholecalciferol and calcium supplement enhances weight loss and improves health biomarkers in obese women.
Subih HS; Zueter Z; Obeidat BM; Al-Qudah MA; Janakat S; Hammoh F; Sharkas G; Bawadi HA
Nutr Res; 2018 Nov; 59():53-64. PubMed ID: 30442233
[TBL] [Abstract][Full Text] [Related]
16. 25-Hydroxyvitamin D response to graded vitamin D₃ supplementation among obese adults.
Drincic A; Fuller E; Heaney RP; Armas LA
J Clin Endocrinol Metab; 2013 Dec; 98(12):4845-51. PubMed ID: 24037880
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D status is not related to insulin resistance in different phenotypes of moderate obesity.
Al Masri M; Romain AJ; Boegner C; Maimoun L; Mariano-Goulart D; Attalin V; Leprieur E; Picandet M; Avignon A; Sultan A
Appl Physiol Nutr Metab; 2017 Apr; 42(4):438-442. PubMed ID: 28177726
[TBL] [Abstract][Full Text] [Related]
18. A 12-week double-blind randomized clinical trial of vitamin D₃ supplementation on body fat mass in healthy overweight and obese women.
Salehpour A; Hosseinpanah F; Shidfar F; Vafa M; Razaghi M; Dehghani S; Hoshiarrad A; Gohari M
Nutr J; 2012 Sep; 11():78. PubMed ID: 22998754
[TBL] [Abstract][Full Text] [Related]
19. A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?
Wood AD; Secombes KR; Thies F; Aucott LS; Black AJ; Reid DM; Mavroeidi A; Simpson WG; Fraser WD; Macdonald HM
Osteoporos Int; 2014 Jan; 25(1):305-15. PubMed ID: 23982800
[TBL] [Abstract][Full Text] [Related]
20. The effect of obesity on the relationship between serum parathyroid hormone and 25-hydroxyvitamin D in women.
Shapses SA; Lee EJ; Sukumar D; Durazo-Arvizu R; Schneider SH
J Clin Endocrinol Metab; 2013 May; 98(5):E886-90. PubMed ID: 23509103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
